The policy under consideration is the latest development in the Trump administration's efforts to boost chip manufacturing in the U.S. The push has also been a boon to Intel's faltering business, in ...

Eli Lilly rises after President Donald Trump announces a 100% tariff on drug products from companies not building manufacturing plants in the U.S.

The latest example is expected to come in the form of what Trump called a “tremendous fee” the U.S. will collect for its part in negotiating an agreement to spin off the Chine ...

Trade Desk has struggled to keep up with the broader S&P 500 Index over the past year, but analysts are fairly bullish on its ...